181 related articles for article (PubMed ID: 16988797)
1. Homocysteine but not neopterin declines in demented patients on B vitamins.
Frick B; Gruber B; Schroecksnadel K; Leblhuber F; Fuchs D
J Neural Transm (Vienna); 2006 Nov; 113(11):1815-9. PubMed ID: 16988797
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Vitamin B Supplementation on Cognition in Elderly Patients With Cognitive-Related Diseases.
Zhang DM; Ye JX; Mu JS; Cui XP
J Geriatr Psychiatry Neurol; 2017 Jan; 30(1):50-59. PubMed ID: 28248558
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinaemia and immune activation in patients with cancer.
Schroecksnadel K; Frick B; Fiegl M; Winkler C; Denz HA; Fuchs D
Clin Chem Lab Med; 2007; 45(1):47-53. PubMed ID: 17243914
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, B Vitamins, and Cognitive Impairment.
Smith AD; Refsum H
Annu Rev Nutr; 2016 Jul; 36():211-39. PubMed ID: 27431367
[TBL] [Abstract][Full Text] [Related]
5. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
Aisen PS; Schneider LS; Sano M; Diaz-Arrastia R; van Dyck CH; Weiner MF; Bottiglieri T; Jin S; Stokes KT; Thomas RG; Thal LJ;
JAMA; 2008 Oct; 300(15):1774-83. PubMed ID: 18854539
[TBL] [Abstract][Full Text] [Related]
6. Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?
Fuchs D; Jaeger M; Widner B; Wirleitner B; Artner-Dworzak E; Leblhuber F
Clin Chem Lab Med; 2001 Aug; 39(8):691-4. PubMed ID: 11592434
[TBL] [Abstract][Full Text] [Related]
7. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
8. Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease.
Widner B; Leblhuber F; Frick B; Laich A; Artner-Dworzak E; Fuchs D
J Neural Transm (Vienna); 2002 Dec; 109(12):1445-52. PubMed ID: 12486485
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
[TBL] [Abstract][Full Text] [Related]
10. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
[TBL] [Abstract][Full Text] [Related]
11. Association Between Homocysteine and Vitamin Levels in Demented Patients.
Hoffmann J; Busse S; von Hoff F; Borucki K; Frodl T; Busse M
J Alzheimers Dis; 2021; 81(4):1781-1792. PubMed ID: 33998538
[TBL] [Abstract][Full Text] [Related]
12. Decreasing plasma endothelin-1 and unchanged plasma neopterin during folate supplementation in hyperhomocysteinemia.
Gottsäter A; Forsblad J; Mattiasson I; Lindgärde F
Int Angiol; 2002 Jun; 21(2):158-64. PubMed ID: 12110777
[TBL] [Abstract][Full Text] [Related]
13. Vitamins and minerals 4: overview of folate and the B vitamins.
Thompson J
Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
[TBL] [Abstract][Full Text] [Related]
14. Relationship between homocysteine and neopterin concentrations in patients with gynecological cancer.
Schroecksnadel K; Frick B; Winkler C; Fuith LC; Fuchs D
Cancer Lett; 2006 Aug; 240(2):198-202. PubMed ID: 16271434
[TBL] [Abstract][Full Text] [Related]
15. B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia.
Cheng D; Kong H; Pang W; Yang H; Lu H; Huang C; Jiang Y
Nutr Neurosci; 2016 Dec; 19(10):461-466. PubMed ID: 24938711
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
17. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials.
Ford AH; Almeida OP
J Alzheimers Dis; 2012; 29(1):133-49. PubMed ID: 22232016
[TBL] [Abstract][Full Text] [Related]
18. Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease.
Murr C; Meinitzer A; Grammer T; Schroecksnadel K; Böhm BO; März W; Fuchs D
Scand J Immunol; 2009 Jul; 70(1):63-7. PubMed ID: 19522769
[TBL] [Abstract][Full Text] [Related]
19. Polyneuropathy and dementia in old age: common inflammatory and vascular parameters.
Leblhuber F; Schroecksnadel K; Beran-Praher M; Haller H; Steiner K; Fuchs D
J Neural Transm (Vienna); 2011 May; 118(5):721-5. PubMed ID: 21286925
[TBL] [Abstract][Full Text] [Related]
20. [Homocysteine lowering with folic acid and B vitamins in vascular disease].
Liakishev AA
Kardiologiia; 2006; 46(5):70. PubMed ID: 16858361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
